Steven A. Silber

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

Daniel S. Ory, Elizabeth A. Ottinger, Nicole Y. Farhat et al. · The Lancet · 2017 · 316 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Clinical Therapeutic +9

Do Formulation Differences Alter Abuse Liability of Methylphenidate?

Dolly A. Parasrampuria, Kerri A. Schoedel, Reinhard Schuller et al. · Journal of Clinical Psychopharmacology · 2007 · 71 citations

Drug Safety, Substance Abuse, Psychoactive Drug +13

Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study

Steven A. Silber, Ermias Diro, Netsanet Workneh et al. · American Journal of Tropical Medicine and Hygiene · 2017 · 32 citations · Full text

Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis

Bruce C. Trapnell, Steven Strausbaugh, Marlyn S. Woo et al. · Journal of Cystic Fibrosis · 2011 · 29 citations

Pancreatic Fluid Collection, Gastroenterology, Pancreatic Surgery +2

Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O,β-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection

Ole Lagatie, Emmanuel Njumbe Ediage, Linda Batsa Debrah et al. · Parasites & Vectors · 2016 · 25 citations · Full text